Ravi Mahalingam

University Of Colorado Denver

$12,014,504

Attributed

$12,014,504

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1M · FY2009–23

$2M$1.5M$1M$500K$0

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$12,014,504 · 4

By mechanism

P01$12,014,504 · 4

Top collaborators

No co-investigators on record.

Most similar at University Of Colorado Denver

Same institution · by research overlap

Maria Acena Nagel$8,256,702
Randall J. Cohrs$10,553,236
Donald Gilden$19,848,267
Kevin Brett Messacar$878,068
Andrew N Bubak$1,693,545

Others in their field

Top investigators on “Chronic”

Judith S. Currier · University Of California Los Angeles$245,012,139
Lawrence Corey · Fred Hutchinson Cancer Center$209,947,290
Glenda E Gray · Wits Health Consortium (Pty), Ltd$201,828,077
Joseph J. Eron · Univ Of North Carolina Chapel Hill$173,476,538
John M Lachin · George Washington University$125,152,883
David M Nathan · Massachusetts Institute Of Technology$120,438,756

Research focus

ChronicCellsVirusVirus DiseasesBloodElderlyMonkeysT-LymphocyteFlow CytometryImmune ResponsePrimatesImmuneGangliaHerpes Zoster DiseaseImmunocompromised HostChickenpoxSkinBaseDendritic CellsGenetic TranscriptionProtocols DocumentationReceptorDown-RegulationAnimals